This study systematically reviewed the literature on the impact of digital genetics tools on patient care and system efficiencies. MEDLINE and Embase were searched for articles published between January 2010 and March 2021. Studies evaluating the use of patient-facing digital tools in the context of genetic service delivery were included. Two reviewers screened and extracted patient-reported and system-focused outcomes from each study. Data were synthesised using a descriptive approach. Of 3226 unique studies identified, 87 were included. A total of 70 unique digital tools were identified. As a result of using digital tools, 84% of studies reported a positive outcome in at least one of the following patient outcomes: knowledge, psychosocial well-being, behavioural/management changes, family communication, decision-making or level of engagement. Digital tools improved workflow and efficiency for providers and reduced the amount of time they needed to spend with patients. However, we identified a misalignment between study purpose and patient-reported outcomes measured and a lack of tools that encompass the entire genetic counselling and testing trajectory. Given increased demand for genetic services and the shift towards virtual care, this review provides evidence that digital tools can be used to efficiently deliver patient-centred care. Future research should prioritise development, evaluation and implementation of digital tools that can support the entire patient trajectory across a range of clinical settings. PROSPERO registration numberCRD42020202862.
- Patient Care
- Genetic Testing
- Genetic Counseling
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
WL and SS contributed equally.
Collaborators Genetics Navigator Study Team: Yvonne Bombard (co-PI), Robin Hayeems (co-PI), Melyssa Aronson, Francois Bernier, Michael Brudno, June Carroll, Lauren Chad, Marc Clausen, Ronald Cohn, Gregory Costain, Irfan Dhalla, Hanna Faghfoury, Jan Friedman, Stacy Hewson, Rebekah Jobling, Rita Kodida, Anne-Marie Laberge, Jordan Lerner-Ellis, Eriskay Liston, Stephanie Luca, Muhammad Mamdani, Christian Marshall, Matthew Osmond, Quynh Pham, Emma Reble, Frank Rudzicz, Emily Seto, Serena Shastri-Estrada, Cheryl Shuman, Josh Silver, Maureen Smith, Kevin Thorpe, Wendy Ungar, Trevor Jamieson.
Contributors Conceptualisation: WL, SS, RH, YB, DA, SL, MC. Data collection: WL, SS, DA, SL, CS, AT, AS. Formal analysis: WL, SS, DA. Funding acquisition: RH, YB. Writing - original draft: WL, SS. Writing - review and editing: DA, SL, MC, CS, AT, AS, RH, YB, WL, SS. Supervision: RH, YB.
Funding This work was supported by the McLaughlin Catalyst Grant through the University of Toronto and a bridge grant from the Canadian Institutes of Health Research (CIHR; 175409).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.